Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,132 | 41,857 | 17,991 | 11,135 | 1,638 |
| Receivables | N/A | N/A | 801 | 1,024 | N/A |
| Other current assets | 148 | 1,998 | 0 | 0 | 0 |
| TOTAL | $40,387 | $43,855 | $18,792 | $12,159 | $1,732 |
| Non-Current Assets | |||||
| PPE Net | 4 | 4 | N/A | 869 | 1 |
| Other Non-Current Assets | 186 | 0 | 1,300 | 4,402 | 45 |
| TOTAL | $189 | $4 | $1,300 | $5,271 | $46 |
| Total Assets | $40,577 | $43,859 | $20,092 | $17,430 | $1,778 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,508 | 5,780 | 5,440 | 5,203 | 598 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,417 |
| TOTAL | $4,604 | $5,780 | $5,440 | $5,203 | $2,016 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 73 | 0 | 716 | 883 | 0 |
| TOTAL | $73 | $N/A | $716 | $883 | $N/A |
| Total Liabilities | $4,677 | $5,780 | $6,156 | $6,086 | $2,016 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 295 | 293 | 193 | 43 | 40 |
| Common Shares | 83 | 81 | 727 | 727 | 19 |
| Retained earnings | -15,671 | -12,455 | -215,212 | -207,780 | -7,960 |
| TOTAL | $35,900 | $38,079 | $13,936 | $11,344 | $-238 |
| Total Liabilities And Equity | $40,577 | $43,859 | $20,092 | $17,430 | $1,778 |